Magnitude of Osteoarthritis disadVantage on pEoples liveS

NCT ID: NCT01423097

Last Updated: 2012-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1015 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-09-30

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Estimate the prevalence of self-reported osteoarthritis and its characterization in adults over 45 years of age:

* Characterization of self-reported patients with OA (socio-demographic, comorbidities, VAS for intensity of pain)
* Characterization of OA diagnosis in patients with self-reported OA
* Impact of self-reported OA in the working abilities, quality of life and functionality (SF-12 v2.0)
* Characterization of treatment approaches (therapeutic and non-therapeutic) for self-reported patients with OA
* Patient perception of impact of OA in its life and importance given to disease

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Magnitude of Osteoarthritis disadvantage on peoples lives.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

osteoarthritis symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Adults over 45 years old with self-reported osteoarthritis

Exclusion Criteria

\- NA
Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Queluz Baixo, Barcarena, Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-RPO-XXX-2011/2

Identifier Type: -

Identifier Source: org_study_id